PEPTIDEIQ CLAIMCHECK · 6 SEP 2026
Semaglutide × Lifespan
Does a 12% mouse lifespan extension mean roughly 10 extra human years?
VERDICT SUMMARY
The 12% lifespan extension is real—in female mice.
The 12% lifespan extension is real—in female mice. The human 10-year extrapolation is not. There is no evidence that the mouse percentage translates proportionally to human lifespan.
THE CLAIM
“GLP-1 extended lifespan by 12% in mice — that is like 10 years for humans. We really found the miracle drug.”
ORIGINAL CLAIM SOURCEX · @iterintellectus · 6 SEP 2026VIEW ORIGINAL POSTEVIDENCE
What the evidence says
CITATION
Nature (2026) · DOI 10.1038/s41586-026-10940-7
DESIGN
20-month-old female C57BL/6 mice · 39 control / 40 semaglutide
SUPPLEMENT
10 nmol/kg semaglutide daily for remaining lifespan
WHAT'S ACCURATE
- Female C57BL/6 mice treated late in life with semaglutide had median lifespan of 834 days versus 742 days in controls—about 12% longer.
WHAT'S MISLEADING
- The experiment tested one mouse strain and one sex; males were not lifespan-tested.
- Mouse longevity percentages cannot be converted directly into human years.
- Treated mice reduced food intake by about 24%, complicating interpretation of a drug-specific longevity effect.
KEY TAKEAWAYS
The 12% lifespan extension is real—in female mice. The human 10-year extrapolation is not. There is no evidence that the mouse percentage translates proportionally to human lifespan.